Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
Eight inhibitors of acetylcholinesterase (AChE), tacrine, bis-tacrine, donepezil, rivastigmine, galantamine, heptyl-physostigmine, TAK-147 and metrifonate, were compared with regard to their effects on AChE and butyrylcholinesterase (BuChE) in normal human brain cortex. Additionally, the IC50 values of different molecular forms of AChE (monomeric, G1, and tetrameric, G4) were determined in the cerebral cortex in both normal and Alzheimer's human brains. The most selective AChE inhibitors, in decreasing sequence, were in order: TAK-147, donepezil and galantamine. For BuChE, the most specific was rivastigmine. However, none of these inhibitors was absolutely specific for AChE or BuChE. Among these inhibitors, tacrine, bis-tacrine, TAK-147, metrifonate and galantamine inhibited both the G1 and G4 AChE forms equally well. Interestingly, the AChE molecular forms in Alzheimer samples were more sensitive to some of the inhibitors as compared with the normal samples. Only one inhibitor, rivastigmine, displayed preferential inhibition for the G1 form of AChE. We conclude that a molecular form-specific inhibitor may have therapeutic applications in inhibiting the G1 form, which is relatively unchanged in Alzheimer's brain.
Rakonczay
Z
Z
Alzheimer's Disease Research Center, Department of Psychiatry, University of Szeged, Szeged, Hungary. RZ@comser.szote.u-szeged.hu
D000110:Acetylcholinesterase / Q000378:metabolism*; D000544:Alzheimer Disease / Q000201:enzymology*; D001552:Benzazepines / Q000494:pharmacology; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D002091:Butyrylcholinesterase / Q000378:metabolism*; D002219:Carbamates / Q000494:pharmacology; D002540:Cerebral Cortex / Q000187:drug effects / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004491:Edrophonium / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D048448:Phenylcarbamates; D010830:Physostigmine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000068836:Rivastigmine; D013619:Tacrine / Q000494:pharmacology; D014236:Trichlorfon / Q000494:pharmacology
D001552:Benzazepines; D002219:Carbamates; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D013619:Tacrine; C052450:physostigmine heptyl; D004491:Edrophonium; C099872:TAK 147; D010830:Physostigmine; D014236:Trichlorfon; D000110:Acetylcholinesterase; D002091:Butyrylcholinesterase; D000068836:Rivastigmine